Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Equity Average (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Equity Average for 6 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Equity Average rose 164.47% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 164.47% year-over-year, with the annual reading at $1.2 million for FY2025, 179.13% up from the prior year.
  • Equity Average for Q4 2025 was $1.6 million at BioScience Health Innovations, down from $1.7 million in the prior quarter.
  • The five-year high for Equity Average was $1.7 million in Q3 2025, with the low at -$71621.0 in Q2 2023.
  • Average Equity Average over 5 years is $347626.0, with a median of $30906.8 recorded in 2021.
  • The sharpest move saw Equity Average tumbled 640.21% in 2021, then soared 65346.42% in 2024.
  • Over 5 years, Equity Average stood at $30163.5 in 2021, then tumbled by 33.91% to $19934.5 in 2022, then plummeted by 95.38% to $921.0 in 2023, then skyrocketed by 65346.42% to $602761.5 in 2024, then skyrocketed by 164.47% to $1.6 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $1.6 million, $1.7 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.